Psoriasis Clinical Trial
A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis
Summary
The study was double-blind, randomized, vehicle-controlled study with application of Ruxolitinib phosphate cream or vehicle cream in participants with stable plaque psoriasis applied once daily for 12 weeks without occlusive dressings. There were 4 treatment groups anticipated to have 50 participants in each.
Eligibility Criteria
Inclusion Criteria:
Plaque psoriasis involving up to 2 to 20% Body Surface Area
Exclusion Criteria:
Lesions solely involving intertriginous areas, the scalp or the face
Systemic therapy for their psoriasis
Pustular psoriasis or erythroderma
Currently on other topical agents or Ultraviolet B (UVB) therapy within 2 weeks of the first dose of study medication
Started or discontinued therapy within 2 months of Screening with agents that can exacerbate psoriasis
Receiving systemic triazole antifungals except fluconazole
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Hot Springs Arkansas, , United States
Los Angeles California, , United States
San Diego California, , United States
Santa Monica California, , United States
Vallejo California, , United States
New Haven Connecticut, , United States
Miami Florida, , United States
Ormond Beach Florida, , United States
Naperville Illinois, , United States
Wheaton Illinois, , United States
Evansville Indiana, , United States
South Bend Indiana, , United States
Boston Massachusetts, , United States
Clinton Township Michigan, , United States
Fridley Minnesota, , United States
Saint Louis Missouri, , United States
Albuquerque New Mexico, , United States
Rochester New York, , United States
Norman Oklahoma, , United States
Simpsonville South Carolina, , United States
Austin Texas, , United States
College Station Texas, , United States
Dallas Texas, , United States
Houston Texas, , United States
Salt Lake City Utah, , United States
Norfolk Virginia, , United States
Walla Walla Washington, , United States
Madison Wisconsin, , United States
How clear is this clinincal trial information?